TRNS
Overvalued by 2.9% based on the discounted cash flow analysis.
Market cap | $743.08 Million |
---|---|
Enterprise Value | $801.13 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.66 |
Beta | 0.67 |
Outstanding Shares | 9,230,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 43.49 |
---|---|
PEG | 7.08 |
Price to Sales | 2.74 |
Price to Book Ratio | 2.65 |
Enterprise Value to Revenue | 2.96 |
Enterprise Value to EBIT | 35.69 |
Enterprise Value to Net Income | 44 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 0.22 |
No data
No data
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly t...